Preparations are well underway for the 24th Annual Scientific Meeting of the ISCP, which will be held on the 9th-10th of May 2019 in Lugano, Switzerland. The meeting has been organized in collaboration with the Working Group on Cardiovascular Pharmacotherapy (European Society of Cardiology), the Swiss Society of Cardiology (SSC) and the Swiss Atherosclerosis Association, the French Society of Cardiology and the Cardiovascular Clinical Trials Forum (CVCT). Information on the 24th Annual Scientific Meeting of the ISCP is available at the conference website www.iscp2019.com. The preliminary programme is included in this Newsletter.
Remember to check the Webinars and Conference Talks, Expert Reviews and Expert Opinions sections on the website. These sections of the website are only accessible to ISCP members. You can also view some of the highlights from ISCP 2018 in Kyoto on the website.
Please forward any news or information on upcoming conferences or meetings that you would like included in the next Newsletter (December 2018) to me at email@example.com by the 23rd of November 2018.
Editors: John McNeil & Lisa Demos
Welcome to the September issue of the ISCP Newsletter. This issue includes information from the ESC meeting in Munich, which was held at the end of August. ISCP had a significant number of lectures and joint symposium with the ESC. Also, please note a release of the most recent version of the European Cardiology Review (ECR), the official journal of ISCP. The ECR will be, in the near future, cited on Pub-Med.
The next ISCP Annual Scientific Meeting will be held in Lugano, Switzerland in May 2019. You can view the excellent preliminary program for this meeting in this Newsletter or on the conference website.
I greatly hope that all ISCP members will be interested in the attractive and growing number of activities undertaken by our society. Enjoy the September issue of the ISCP Newsletter, and we look forward to seeing everybody in Lugano next May!
Prof Koji Hasegawa,
Chair, 23rd Annual Scientific Meeting of ISCP
The Co-Presidents of the Organizing Committee for the 24th Annual Scientific Meeting are Augusto Gallino and Juan Carlos Kaski and the Course Directors are: Augusto Gallino, Juan Carlos Kaski, Alexandre Fredenrich, and Heinz Drexel.
The ISCP wishes to encourage the participation of young researchers, MD and PhD students – three Young Investigator Awards will be awarded to the three best posters in this category. There will be ample opportunity during the meeting for the attendees to meet colleagues and experts in different fields of cardiovascular medicine.
ISCP 2019, Lugano – Preliminary Program
|08.15 – 09.35||WORLD EPIDEMICS – Joint Session with ESC Working Group on Cardiovascular Pharmacotherapy
Chairpersons: Thomas Kahan (Stockholm, SE), Antoni Martinez-Rubio (Barcelona, ES), Hector Ventura (New Orleans, US), Luca Gabutti (Bellinzona, CH)
|08.15 – 08.30||Dyslipidemia – new challenges and how to achieve targets Heinz Drexel (Feldkirch, AT)|
|08.30 – 08.45||Hypertension – the many faces of systemic hypertension Celso Amodeo (Sao Paulo, BR)|
|08.45 – 09.00||The management of patients with diabetes and heart failure: the start of a new era? Felipe Martinez (Cordoba, AR)|
|09.00 – 09.15||Smoking and obesity – rationale of a complex interplay: a global overview Koji Hasegawa (Kyoto, JP)|
|09.15 – 09.35||Discussion|
|09.35 – 10.35||A CHANGING PARADIGM IN MANAGEMENT OF DYSLIPIDEMIA
Chairpersons: Koji Hasegawa (Kyoto, JP), Arnold von Eckardstein (Zurich, CH), Alexandre Fredenrich (Nice, FR), Heinz Drexel (Feldkirch, AT)
|09.35 – 09.50||The discovery of PCSK9 Catherine Boileau (Paris, FR)|
|09.50 – 10.05||Opportunities and barriers for the successful clinical utilisation of PCSK9 Michel Farnier (Dijon, FR)|
|10.05 – 10.20||PCSK9 – focus on non-hepatic locations and non LDL-cholesterol metabolism related functions Alberico L. Catapano (Milano, IT)|
|10.20 – 10.35||Discussion|
|10.35 – 11.05||--- Coffee Break ---|
|11.05 – 12.20||ANTI-INFLAMMATORY TREATMENT IN CORONARY ARTERY DISEASE
Chairpersons: Filippo Crea (Rome, IT), Giuseppe Vassalli (Lugano, CH), Alberto Lorenzatti (Cordoba, AR)
|11.05 – 11.25||The rationale for anti-inflammatory treatment Peter Libby (Boston, US)|
|11.25 – 11.40||“in vivo” evidence of the inflammatory hypothesis in humans Augusto Gallino (Bellinzona, CH|
|11.40 – 11.55||The clinical evidence: targeting interleukin-1β: the CANTOS trial Luigi M. Biasucci (Rome, IT)|
|11.55 – 12.10||A word of caution Juan Carlos Kaski (London, GB)|
|12.20 – 13.20||--- Lunch ---|
|13.20 – 14.10||MEDICAL VS INVASIVE TREATMENT STRATEGIES IN STABLE CORONARY ARTERY DISEASE: DEBATE SESSION
Chairpersons: Koji Hasegawa (Kyoto, JP), Edgardo Escobar (Santiago, CL), Marco Moccetti (Lugano, CH), Claudio Ceconi (Ferrara, IT)
|13.20 – 13.35||Too many patients in Europe undergo endovascular treatment for stable coronary artery disease instead of optimal medical treatment – review of recent evidence Filippo Crea (Rome, IT)|
|13.35 – 13.50||Missed opportunities for successful myocardial revascularisation in stable coronary artery disease Stefan Windecker (Bern, CH)|
|13.50 – 13.55 13.55 – 14.00||Rebuttal Filippo Crea (Rome, IT) Rebuttal Stefan Windecker (Bern, CH)|
|14.00 – 14.10||Discussion|
|14.10 – 15.10||EMERGING INDICATIONS FOR NEW ORAL ANTICOAGULATION IN STABLE CORONARY ARTERY DISEASE
Chairpersons: Gheorghe Dan (Bucharest, RO), Juerg H. Beer (Baden, CH), Antoni Martinez-Rubio (Barcelona, ES), Roberto Corti (Zurich, CH)
|14.10 – 14.25||The discovery of Rivaroxaban Elisabeth Perzborn (Wuppertal, DE)|
|14.25 – 14.40||NOACs in acute coronary syndrome and after coronary stent in patients with atrial fibrillation Giovanni B. Pedrazzini (Lugano, CH)|
|14.40 – 15.00||Advances in anticoagulant therapies; from Aspirin to NOACs Salim Yusuf (Hamilton, CA)|
|15.00 – 15.10||Discussion|
|15.10 – 15.40||--- Coffee Break ---|
|15.40 – 16.25||ANTITHROMBOTIC TREATMENT IN ACUTE CORONARY ARTERY DISEASE IN THE WORLD OF EMERGING STENTS
Chairpersons: Felipe Martinez (Cordoba, AR), Daniel Suerder (Lugano, CH)
|15.40 – 15.55||State of the art of antithrombotic prevention Gilles Montalescot (Paris, FR)|
|15.55 – 16.10||Will emerging stents simplify antithrombotic treatment? Marco Roffi (Geneva, CH)|
|16.10 – 16.25||Discussion|
|16.25 – 17.20||A JOINT MEETING WITH THE CARDIOVASCULAR CLINICAL TRIALS FORUM (CVCT)|
|17.20 – 17.50||NEUFELD LECTURE
Chairpersons: Juan Carlos Kaski (London, GB), Tiziano Moccetti (Lugano, CH), Koji Hasegawa (Kyoto, JP), Augusto Gallino (Bellinzona, CH)
|The Polypill: A simple, inexpensive approach to reduce mortality and morbidity worldwide Salim Yusuf (Hamilton, CA)|
|17.50 – 18.35||THE EMERGING ROLE OF PCSK9 INHIBITORS AFTER ACS
Chairpersons: Alberico L. Catapano (Milano, IT), Alberto Lorenzatti (Cordoba, AR), Giorgio Noseda (Mendrisio, CH), Heinz Drexel (Feldkirch, AT)
|17.50 – 18.05||Tackling the residual risk Alvaro S. Liprandi (Buenos Aires, AR)|
|18.05 – 18.20||The emerging role of PCSK9 inhibitors after an acute coronary event: successful return after an Odyssee François Mach (Geneva, CH)|
|18.20 – 18.35||Discussion|
|18.35 – 19.00||ISCP AWARDS
Augusto Gallino (Bellinzona, CH), Juan Carlos Kaski (London, GB)
|18.35 – 18.45||A brief retrospective of the ISCP Wilhelm Rutishauser (Geneva, CH)|
|18.45 – 19.00||ISCP Posters Awards|
|08.15 – 09.30||ATRIAL FIBRILLATION
Chairpersons: Carlos Morillo (Calgary, CA), Geneviève Derumeaux (Créteil, FR), Ali Oto (Ankara, TR), Andrea Menafoglio (Bellinzona, CH)
|08.15 – 08.30||Antiarrhythmic drugs for atrial fibrillation – State of the art Gheorghe Dan (Bucharest, RO)|
|08.30 – 08.45||Advances in curative approaches Angelo Auricchio (Lugano, CH)|
|08.45 – 09.00||Neurocognitive function in atrial fibrillation and anticoagulation: lessons from the Swiss atrial fibrillation cohort study Stefan Osswald (Basel, CH)|
|09.00 – 09.15||Stroke prevention: state of the art Antoni Martinez-Rubio (Barcelona, ES)|
|09.15 – 09.30||Discussion|
|09.30 – 10.10||CHRONIC HEART FAILURE: A PARADIGM SHIFT
Chairpersons: Georg Noll (Zurich, CH), Giuseppe Rosano (London, GB), Hector Ventura (New Orleans, US)
|09.30 – 09.45||A paradigm shift in the treatment of heart failure Karl Swedberg (Gothenburg, SE)|
|09.45 – 10.00||Devices for management of heart failure Frank Ruschitzka (Zurich, CH)|
|10.00 – 10.10||Discussion|
|10.10 – 10.40||--- Coffee Break ---|
|10.40 – 11.15||KEY LECTURE – ACUTE HEART FAILURE
Chairpersons: Basil Lewis (Haifa, IL), Thomas Suter (Bern, CH), Maurizio Volterrani (Rome, IT), Marcello Di Valentino (Bellinzona, CH)
|10.40 – 11.00||Acute heart failure: death risk higher than heart attack but care lags 30 years behind Christian Mueller (Basel, CH)|
|11.00 - 11.15||Discussion|
|11.15 – 11.45||STATE OF THE ART LECTURE
Chairpersons: Thomas Kahan (Stockholm, SE), Ferenc Follath (Lugano, CH), Juan Carlos Kaski (London, GB)
|11.15 – 11.45||Translational medicine and reverse in cardiovascular pharmacotherapy Thomas Luescher (London UK, Zurich, CH)|
|11.45 – 12.45||NEW ANTIDIABETIC DRUGS IMPROVE CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE AND DIABETES
Chairpersons: Alexandre Fredenrich (Nice, FR), Heinz Drexel (Feldkirch, AT), Michael Zellweger (Basel, CH)
|11.45 – 12.00||SGLT2 inhibitors: a change of paradigm in the treatment of cardiac failure Philippe van de Borne (Brussels, BE)|
|12.00 -- 12.15||Beyond the EMPA-REG trials SGLT2 inhibitors in Heart failure patients without diabetes (the EMPEROR trials) Alexandre Fredenrich (Nice, FR)|
|12.15 – 12.30||Emerging REAL-world Data versus clinical randomized data Heinz Drexel (Feldkirch, AT)|
|12.30 – 12.45||Discussion|
|12.45 – 13.15||KEY LECTURE|
|12.45 – 13.05||Cardiovascular effects of incretin-based therapies: lessons from the trials testing GLP1 RAs Aldo Maggioni (Firenze, IT)|
|13.05 – 13.15||Discussion|
|13.15 – 14.15||--- Lunch ---|
|14.15 – 15.15||ARTERIAL HYPERTENSION
Chairpersons: Georg Noll (Zurich, CH), Celso Amodeo (Sao Paulo, BR), Franco Muggli (Lugano, CH)
|14.15 – 14.30||The hypertension paradox – more uncontrolled disease despite improved therapy Gianfranco Parati (Milano, IT)|
|14.30 – 14.45||Target blood pressure in patients at high cardiovascular risk Thomas Kahan (Stockholm, SE)|
|14.45 – 15.00||Antihypertensive treatment in the very elderly Georg Noll (Zuerich,CH)|
|15.00 – 15.15||Discussion|
|15.15 – 16.00||VENTRICULAR AND ATRIAL REMODELING – THE ROAD TO HEART FAILURE AND STROKE: FUTURE APPROACHES. A joint Session with the French Society of Cardiology
Chairpersons: Antoni Martinez-Rubio (Barcelona, ES), Gheorghe Dan (Bucharest, RO), Denis Cokkinos (Athens, GR)
|15.15 – 15.30||Cardiac remodeling in metabolic cardiomyopathy Geneviève Derumeaux (Créteil, FR)|
|15.30 – 15.45||Left ventricular architecture, long-term reverse remodeling and clinical outcome: lessons from the REVERSE trial Jean-Claude Daubert (Rennes, FR)|
|15.45 – 16.00||Discussion|
Prof Sang Hong Baek, ISCP Governor for Korea reported that the Inaugural Scientific Meeting of the ISCP Korea Chapter held in Seoul on the 15th of June was a success.
During the ESC Congress a joint symposia was held between ISCP and the ESC working group on cardiovascular pharmacotherapy. The session titled “Adherence to Medication and CV Outcome” was chaired by Prof Antoni Martinez-Rubio (ISCP) and Prof Stefan Agewal (WG CVP) and the presenters were Prof G. Andrei Dan (How To Monitor Adherence), Antoni Martinez-Rubio (Cost Of Non-Adherence), LM Hill (Nurse Support Care And Drug Adherence) and RP Giugliano (The Effect Of Medication Adherence On Prognosis). There was a large audience of more than 100 people, the session was very interactive and the symposium satisfied the scientific and educational targets.
Prof Gheorghe-Andrei Dan also participated in a “Meet the Experts” session organized in conjunction with EMA on the adverse effects of the new CV drugs.
Around 80 ESC delegates visited the ISCP booth and signed up as new ISCP Members.
The Current Cardiovascular Therapy Series is created with the support of the ISCP. The books provide both an in-depth view of the science and pharmacology behind these drugs and a practical guide to their usage. Each volume is designed to be between 120 and 250 pages, containing practical illustrations and designed to improve understanding and practical usage of cardiovascular drugs in specific clinical areas.
The series currently includes 9 books: Antiplatelet and Anticoagulation Therapy; Pharmacological Treatment of Acute Coronary Syndromes; Atrial Fibrillation Therapy; Cardiac Drugs in Pregnancy; Pharmacotherapy in Aortic Disease; Pharmacologic Trends of Heart Failure; Pharmacological Treatment of Chronic Stable Angina Pectoris; ACEi and ARBS in Hypertension and Heart Failure; Treatment of Pulmonary Hypertension.
The books are available as e-books or in soft cover at a discounted rate for ISCP members.
The European Cardiology Review is a peer-reviewed bi-annual journal comprising review articles, editorials and case reports. The journal is led by Editor-in-Chief Juan Carlos Kaski, supported by Associate Editors, and underpinned by an editorial board of world-renowned physicians. The latest edition, Volume 13, Issue 1 2018, was released in August 2018 and is accessible to all members via the website.
The ECR is a free on-line review that is accessible via the ECR website.
For information on submitting an article, please contact the Managing Editor, Lindsey Mathews: firstname.lastname@example.org
World Heart Day Resources: including logo, posters and Facebook cover are now available in several languages including Arabic, Chinese, Dutch, French, German, Greek, Italian, Japanese, Korean, Malay, Polish, Portuguese, Romanian, Serbian, Slovenian and Spanish. World Heart Day is on the 29 September 2018.
WCC 2019 to be held in Paris together with ESC: This will be the first World Congress of Cardiology under a new model, which will see the congress taking place every year, rather than every two years, in collaboration with another cardiology meeting. The main spotlight of the Paris congress will be Global Health. The joint ESC-WCC congress will be held from 31 August to 4 September at the Paris Convention Centre.
The Global Coalition for Circulatory Health will launch the White Paper for Circulatory Health on the 25th of September at the Harvard Club in New York City. Aimed at policymakers in national and international bodies, the White Paper is a solution-oriented paper that draws on success stories and patient testimonies to present feasible actions in education and training, universal health coverage, financing, infrastructure, and access to medicines and technologies to advance circulatory health.
Global Summit on Circulatory Health: will be held in Dubai between 4th – 5th of December and will take a novel and practical approach to the theme of Access to Medicines and Technologies. Including universal health coverage, procurement, monitoring and surveillance, and prescribing by health workers. Key opinion leaders in government, civil society, academia and the private sector will propose specific calls to action at the Global Summit and engage in interactive presentations, case studies, and debate.
WCC2018: The World Congress on Cardiology and Cardiovascular Health is in Dubai from 5th-8th December 2018. The congress will include a Meet and Share Forum for leaders in the field of cardiovascular health to come together and discuss obstacles, share success stories and consider best practice implementation in the global fight against cardiovascular disease and a new forum for non-medical professionals. Online Scientific Programme: this highly interactive programme was developed to encourage debate and best practice sharing from across the cardiovascular health community. WCC TV will produce a new daily episode during the conference.
23rd ASEAN Federation of Cardiology Congress
28 September – 1 October 2018
44° Congreso Argentino de Cardiología
18 – 20 October 2018
Buenos Aires, Argentina
39th Panhellenic Congress of Cardiology
18 – 20 October 2018
27th European Cardiology Conference
22 – 24 October 2018
29 November – 1 December 2018
28 October 2018
Tel Aviv, Israel
American Heart Association Scientific Sessions 2018
10 – 14 November 2018
3rd Global Summit on Circulatory Health
4 – 5 December 2018
5 – 8 December, 2018
ESC Congress 2019
31 August – 4 September 2019
To unsubscribe to the Newsletters please notify: Begoña Lugg the ISCP Administration Officer at email@example.com or fax: +44 (0)20 8725 3416